This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and reliability standards.
To address the growing physician shortage, some people argue that the scope of practice should be expanded for skilled healthcare professionals like nurse practitioners and pharmacists. He argued that throwing other professionals into physicians’ roles will have poor ramifications of patient safety.
On the other, it raises alarms about safety, oversight, and the risk of delayed care. The self-medicating plant movement sits at the intersection of empowerment and misinformation. On one hand, it signals a growing desire for agency in personal health.
Providers, administrators, health insurers and other healthcare-access gatekeepers can learn, train, change policies and remove barriers facing vulnerable groups so they can receive the long-overdue opportunity to pursue their best health and well-being.
These are consumers who have relatively firm personal conviction in their decision to get vaccinated and may well be “first in line” when a vaccine is available to them—assuming continued positive safety and efficacy evidence. Importantly, they want to receive information from trusted sources, namely physicians.
Through collaboration between regulators and healthcare stakeholders, telehealth prescribing can continue to expand treatment access while maintaining proven safety standards. The post Navigating Virtual Prescribing Policy Changes in 2025 appeared first on MedCity News.
The key is to continue to embrace new breakthroughs – with strong guardrails for safety, privacy and transparency. As Gen AI continues to mature, there will be ways to employ these technologies thoughtfully and safely in healthcare today. The post Eliminating the AI ‘Black Box’ to Make Clinical Data Usable appeared first on MedCity News.
They research the drug online and ask their physician about it if they decide it’s a treatment option. 3hree: DTC marketing minimizes the side effects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.” This is perhaps the biggest misunderstanding.
While a physician may determine a treatment plan, they must get the insurers green light to ensure coverage. Patient Safety Prior authorization protects patients by: Verifying that prescribed medications or treatments are safe. Level 3: External review by an impartial physician. Why Does Prior Authorization Exist?
Accelerated Approval allows for early access to drugs and biologics based on initial evidence of safety and effectiveness, while confirmatory studies required to verify clinical benefits are ongoing. The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012. Do patients care? Do patients care?
King said: And so not having that in a single area, single curated type of place makes it very difficult to really gain insights out of that data and to be able to have actionable things for a provider or a physician or a hospital operator to make decisions on how we can improve and better patient care. October 8 was when I saw it in action.
J&J’s refusal to release any information regarding a COVID-19 vaccination trial that J&J paused earlier this month comes on the heels of a recent and widely-touted joint pledge of prudence and caution on vaccine trial safety by nine drug companies, including J&J, working on COVID 19 vaccines.
The reality is that physicians, patients, and caregivers are active on platforms like LinkedIn, Twitter (X), Instagram, and even TikTok. Video case studies, physician explainers, and patient journey documentaries all perform well. Twitter (X) Remains relevant for HCP engagement and breaking news.
This article deals on the psychology of selling to physicians. In the medical trade, it is normal for the physician to interact with numerous medical representatives. Normally, a physician would choose and deal with a few reps on a regular basis. The Exceptional Sales Representative and Physician Relationship.
Up to now, drug safety teams have relied primarily on reactive reporting systems for pharmacovigilance (PV) or real-world drug safety monitoring. Physicians must form hypotheses about the AE’s cause and seek information to prove or discredit the hypothesis. Yet, correlation does not signify causation.
Marketing to doctors, physicians, surgeons, and other health care professionals can be extremely challenging, complicated, and expensive. Today's traditional and digital marketing technologies offer unprecedented opportunities to reach physicians and other health care professionals cost-effectively—and at scale.
Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies.
How do physicians feel about patients asking for a new drug via a telehealth visit, and can the prescriber evaluate whether a patient is a good candidate or a new drug? They’re going to go online where they can read the safety warnings that too often than not scare them because they lack context. Is TV the best channel?
biosimilars market is evolving rapidly and pharma marketing programs need to evolve as well to better meet physician needs. As we found in our latest physician survey, physicians are actively seeking more information on key topics such as patient affordability, patient eligibility, clinical results, formulary coverage, and more.
And as generative AI, real-world evidence, and physician-level targeting reshape the rules, only agile marketers will keep up. Physicians want peer-reviewed studies, mechanism-of-action animations, and case-based outcomes. Every content piece must go through medical, legal, and regulatory review to ensure accuracy and safety.
In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services.
About 40 percent of drugs fail in preliminary Phase I studies, which assess a drug’s safety in humans and typically cost just $25 million. After all, 90 percent of all drugs that enter human testing fail. But most of these failures occur early and at relatively low costs.
EBT-101, a CRISPR-Cas9 gene editing system delivered by adenovirus-associated virus vector serotype 9 (AAV9) has been administered to the first individual in a Phase I/II trial designed to establish its safety and efficacy. Biodistribution, pharmacodynamic, and efficacy assessments will also be conducted. “It
In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services.
Many hospitals want to support their physicians in expanding their expertise by providing useful educational resources. Safety and Security: Geriatricians and Pediatricians mainly manage patients who are either too old or too young to take care of themselves. Now hospitals and elderly homes can ensure the safety of their charges.
The new Phase II data, in addition to existing studies, add to evidence that domvanalimab has a differentiated safety and tolerability profile relative to published data from studies with Fc-enabled anti-TIGIT antibodies.
Simpson alleged in a lawsuit filed in the District of New Jersey that Bayer paid kickbacks to physicians and hospitals to prompt them to use Trasylol and Avelox. Additionally, the company was accused of downplaying Trasylol’s safety risks. Later on, the company withdrew Trasylol and Baycol from the market for safety reasons.
CMS will delay the requirement for an in-person visit with the physician/practitioner (and FQHCs/RHCs) within 6 months prior to an initial mental health telehealth service, and again at subsequent intervals for purposes of diagnosis/evaluation/treatment of a mental health disorder.
Today’s approval offers physicians and patients in the EU more flexibility to determine the right treatment plan and enables more patients to potentially benefit from this medicine,” explained Dave Fredrickson, Executive Vice President of AstraZeneca’s Oncology Business Unit.
Tools from providers like eHealthcare Solutions allow for scalable review processes, speeding up campaign approval without sacrificing safety. A physician-focused LinkedIn campaign should look and sound very different from an awareness campaign on Instagram. Still, human oversight is critical. And its moving fast.
Syfovre has been approved for use in people with GA with or without subfoveal involvement and offers dosing flexibility with a regimen of every 25 to 60 days for patients and physicians. Syfovre’s safety profile is well-demonstrated after approximately 12,000 injections over 24 months.
In addition, pooled analysis results from the combined primary efficacy endpoint and safety data from RADIANCE SOLO, RADIANCE TRIO, and RADIANCE II were concurrently published in JAMA Cardiology. The study also achieved its primary safety composite outcome with no major adverse events observed. mmHg, compared to a reduction of -1.8
The results presented at EACS complement the results observed in multiple Phase III clinical trials, which demonstrate the sustained efficacy, safety profile, and high barrier to resistance of Biktarvy,” stated Dr Fernando Bognar, Vice President of Global Medical Affairs for HIV at Gilead Sciences.
Other efficacy measures showed significantly improvement: skin thickness (defined by the modified Rodnan Skin Score, mRSS), lung function (percentFVC), physician-reported assessment and quality of life evaluations. The study safety profile of the oral therapy demonstrated that FT011 was safe and well tolerated.
Gardner Family Center for Parkinson’s Disease Research Endowed Chair in UC’s Department of Neurology and Rehabilitation Medicine and a physician at the UC Gardner Neuroscience Institute explained. and Joan A. He noted that this means the treatment dose needs to be increased or administered more often.
“We are pleased to join this collaborative effort to develop and assess the safety, immunogenicity, and effectiveness of an adenovirus type 4-based vaccine expressing the SARS-CoV-2 spike protein as a novel approach to the prevention of COVID-19,” commented Dr Peter Wright, infectious disease, and international health physician at Dartmouth Health’s (..)
Whether you are in the pharmaceuticals, dermoceuticals, OTC, medical devices, or whatever business relates with patients and their health, you need to have a clearly defined strategy on how to approach physicians. Selling to private practice doctors is different than selling to healthcare organizations.
There was also encouraging safety data observed within a wider group of 92 patients: 3% of patients experienced Grade 3 or higher cytokine release syndrome (CRS) and 8% experienced Grade 3 or higher immune effector cell-associated neurotoxicity syndrome (ICANS). Obe-cel showed comparable expansion and initial persistence (median follow-up 6.4
Therefore, with data showing that iptacopan is an “efficacious oral treatment with a demonstrated safety profile [this] could be practice-changing for physicians and help relieve burdens experienced by people with PNH,” Dr Pullarkat added. Patients avoiding transfusion: The transfusion avoidance rate was 95.2 percent for anti-C5.
GlobalData anticipates that this safety update will likely raise physician and regulator vigilance regarding long-term Dupixent use but is unlikely to impact overall prescribing patterns for the product. This will, however, likely trigger Dupixent’s competitors to look more closely at the safety of their products.
A patient’s physician or healthcare provider can decide what treatment the patient needs. Patient safety Patient safety is paramount. Level three: If still unsatisfactory, the appeal may go to a neutral party, often a physician with a similar specialty as the appealing doctor. What is prior authorization?
Physicians and patients raise legitimate questions and concerns about the safety, effectiveness, and accessibility of telehealth. Wearable technology allows physicians to check in on the health of their patients in between physical office visits. Still though, there are obstacles around a vast adoption of telehealth services.
In another unique partnership, the American College of Chest Physicians (CHEST) is teaming up with the nonprofit Three Lakes Foundation on an initiative called “Bridging Specialties: Timely Diagnosis for ILD Patients.” But ultimately, you need multiple modes of education across several formats to have the most impact.”.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content